Wellbutrin Plaintiffs Step Up Fight For Docs' Release
The direct purchaser plaintiffs in an antitrust class action alleging that Biovail Corp. and GlaxoSmithKline PLC conspired to stifle the market for a generic version of antidepressant Wellbutrin XL have charged...To view the full article, register now.
Already a subscriber? Click here to view full article